CONMED Corporation
CNMD
$38.46
-$0.95-2.41%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.37B | 1.35B | 1.33B | 1.32B | 1.31B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37B | 1.35B | 1.33B | 1.32B | 1.31B |
| Cost of Revenue | 634.25M | 586.44M | 575.74M | 575.18M | 573.78M |
| Gross Profit | 740.48M | 761.04M | 750.51M | 740.82M | 733.23M |
| SG&A Expenses | 556.08M | 553.12M | 540.90M | 534.27M | 519.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.25B | 1.19B | 1.17B | 1.16B | 1.15B |
| Operating Income | 128.51M | 153.76M | 155.80M | 152.77M | 159.52M |
| Income Before Tax | 71.12M | 85.51M | 137.69M | 145.28M | 163.03M |
| Income Tax Expenses | 24.06M | 21.44M | 27.49M | 26.53M | 30.61M |
| Earnings from Continuing Operations | 47.06 | 64.07 | 110.20 | 118.75 | 132.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 47.06M | 64.07M | 110.20M | 118.75M | 132.42M |
| EBIT | 128.51M | 153.76M | 155.80M | 152.77M | 159.52M |
| EBITDA | 201.59M | 225.80M | 227.20M | 223.44M | 229.98M |
| EPS Basic | 1.52 | 2.07 | 3.57 | 3.85 | 4.29 |
| Normalized Basic EPS | 1.95 | 2.44 | 2.45 | 2.36 | 2.48 |
| EPS Diluted | 1.51 | 2.05 | 3.53 | 3.80 | 4.24 |
| Normalized Diluted EPS | 1.94 | 2.43 | 2.43 | 2.34 | 2.45 |
| Average Basic Shares Outstanding | 123.85M | 123.80M | 123.70M | 123.57M | 123.37M |
| Average Diluted Shares Outstanding | 124.29M | 124.40M | 124.46M | 124.52M | 124.64M |
| Dividend Per Share | 0.60 | 0.80 | 0.80 | 0.80 | 0.80 |
| Payout Ratio | 52.59% | 38.60% | 22.42% | 20.78% | 18.62% |